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Abstract
Background: The inflammatory cell product neopterin is elevated in serum before and during delirium. This
suggests a role for disordered cell-mediated immunity or oxidative stress. Cerebrospinal fluid (CSF) neopterin levels
reflect brain neopterin levels more closely than serum levels. Here we hypothesized that CSF neopterin levels
would be higher in delirium.
Methods: In this prospective cohort study, 139 elderly patients with acute hip fracture were recruited in Oslo and
Edinburgh. Delirium was diagnosed with the confusion assessment method performed daily pre-operatively and on
the first 5 days post-operatively. Paired CSF and blood samples were collected at the onset of spinal anaesthesia.
Neopterin levels were measured using high-performance liquid chromatography.
Results: Sixty-four (46 %) of 139 hip fracture patients developed delirium perioperatively. CSF neopterin levels were
higher in delirium compared to controls (median 29.6 vs 24.7 nmol/mL, p = 0.003), with highest levels in patients
who developed delirium post-operatively. Serum neopterin levels were also higher in delirium (median 37.0 vs 27.
1 nmol/mL, p = 0.003). CSF neopterin remained significantly associated with delirium after controlling for relevant
risk factors. Higher neopterin levels were associated with poorer outcomes (death or new institutionalization) 1 year
after surgery (p = 0.02 for CSF and p = 0.03 for serum).
Conclusions: This study is the first to examine neopterin in CSF from patients with delirium. Our findings suggest
potential roles for activation of cell-mediated immune responses or oxidative stress in the delirium process. High
levels of serum or CSF neopterin in hip fracture patients may also be useful in predicting poor outcomes.
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Background
Delirium is a serious acute neuropsychiatric syndrome
comprising acute and fluctuating deterioration in atten-
tion, cognition, perception, and level of consciousness [1].
Although delirium is extremely common [2], distressing
[3] and associated with multiple adverse outcomes [4], the
pathophysiology of delirium is still poorly understood [5]
and there are no specific treatments.
There has been much speculation that delirium may
involve inflammation. This is because infection is a
frequent precipitant of delirium and human studies
have found elevated pro-inflammatory cytokines in serum
[6, 7] and cerebrospinal fluid (CSF) [6, 8] in patients with
delirium. Animal studies further support a role for inflam-
mation: in the presence of pre-existing neurodegenerative
disease, moderate peripheral inflammatory stimulus in-
duces a delirium-like transient behavioural change in
conjunction with an exaggerated central inflammatory
response [9, 10]. Though multiple mechanisms may be
implicated, there is some evidence for a role of disor-
dered cell-mediated immunity in delirium. Interferon-γ
(IFN-γ) is important in stimulating the cell-mediated
response, and higher baseline serum IFN-γ levels are
associated with more severe delirium [11] and higher
6-month mortality [12]. There may also be a role for
disordered oxidative stress in delirium. With its high
metabolic demands, and poor antioxidant capabilities,
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the brain is highly vulnerable to damage from oxidative
stress, and this could plausibly result in neuronal dysfunc-
tion under certain conditions [13]. Cardiopulmonary bypass
surgery is a high-risk state for oxidative stress, and these
pathways have been examined in post-operative delirium
[13]. Karlidag et al. demonstrated that low pre-operative
levels of the antioxidant enzyme catalase in blood predis-
posed to post-operative delirium after cardiac surgery [13].
Delirium in ICU patients is also associated with impaired
oxidative metabolism [14].
The pteridine neopterin [15] was first isolated in 1963.
In humans, neopterin is synthesized by monocytes, mac-
rophages, microglia, and dendritic cells from guanosine
triphosphate (GTP) in response to IFN-γ from activated
CD4+ and CD8+ T cells and natural killer cells [15, 16].
Recently, neopterin has been shown to have a role in
oxidative stress. It amplifies the cytotoxicity of reactive
oxygen species from the macrophage oxidative burst,
thereby increasing the cytocidal effects of the cell-mediated
immune response [16]. Neopterin is being studied in many
fields as a biomarker both for cell-mediated immunity and
oxidative stress [16].
In the central nervous system (CNS), neopterin is pro-
duced by microglia [17]. CSF levels are elevated in CNS
infections and in HIV, particularly HIV with concomi-
tant neuropsychiatric sequelae [18]. Plasma levels of
neopterin are elevated in Alzheimer’s dementia and cor-
relate with cognitive decline [19]; however, levels in CSF
were unchanged in one study comparing 20 patients
with Alzheimer’s dementia with age- and sex-matched
controls [20].
Neopterin levels have been little studied in delirium.
Osse et al. have shown that high pre-operative plasma
neopterin levels predict post-operative delirium follow-
ing cardiac surgery, and high post-operative serum levels
were also associated with delirium [21]. High plasma
neopterin levels were associated with delirium in a study
of elderly patients acutely admitted to a medical ward
[22]. No studies have examined CSF neopterin levels in
delirium.
This study tested the hypothesis that neopterin is el-




Hip fracture patients were recruited from Oslo Univer-
sity Hospital, Norway, between 2009 and 2012, and from
the Royal Infirmary of Edinburgh, Scotland, between
2009 and 2011.
All patients recruited in Oslo were part of a random-
ized controlled trial evaluating the effect of an orthoger-
iatric model where hip fracture patients were treated in
an acute geriatric ward [23]. There were no exclusion
criteria related to place of living or age in the Oslo sam-
ple. However, patients were only included if the fracture
was caused by a low energy trauma (defined as a fall
from less than 1 metre). In Edinburgh, patients were ex-
cluded if they were under the age of 60, were nursing
home residents, had significant Parkinson’s disease or had
malignant or other comorbid disease such that prognosis
was less than one year.
The patients were recruited in the emergency room by
a member of the orthopaedic surgical team in Oslo and
by a geriatrician (RH) in the Orthopaedic Trauma Unit
in Edinburgh. Only patients who had both CSF and a
pre-operative serum sample collected after recruitment
were included in the present analysis.
Assessments and procedures
Patients were screened for delirium once daily with the
confusion assessment method (CAM) [24]. All patients
were assessed pre-operatively and until day 5 post-opera-
tively. Delirious patients were assessed until discharge. A
geriatrician (LOW) and a trained research nurse per-
formed the assessments in Oslo. In Edinburgh, one geria-
trician (RH) did all the assessments.
In both hospitals, the CAM scores were based on
information from nurses, close relatives and hospital
records, in combination with a 10- to 30-min interview
with the patient. Details of the delirium assessments
were previously described [25]. Patients were regularly
assessed on weekdays only, but staff members that had
been working during weekends were interviewed every
Monday and the case notes scrutinized for evidence of
delirium. All sections of the notes were examined, and
any comments on change in mental status were recorded.
Delirium severity was assessed with the Memorial De-
lirium Assessment Scale (MDAS) [26] in Oslo and the
Delirium Rating Scale Revised-98 (DRS-R98) [27] in
Edinburgh. MDAS and DRS-R98 scores have a very high
level of agreement, and to enable comparison, MDAS
scores were generated retrospectively on patients in
Edinburgh using a validated conversion rule [28].
The Informant Questionnaire on Cognitive Decline
in the Elderly (IQCODE), 16 item version, was used as
a measure of pre-fracture cognitive status [29]. The
IQCODE was completed based on an interview with a
close relative, staff in the nursing home or home nurs-
ing team, asking the informant to judge the responses
based on patient’s status when last stable before the
present fracture. A cutoff of 3.44 was used as an indicator
of pre-fracture cognitive impairment [29]. In Oslo, the
Barthel ADL Index [30] (0–20 scoring) was scored based
on information from the same informants, emphasizing
the person’s pre-fracture status. In Edinburgh, the Katz
ADL [31] was used. Independence in ADL was defined as
a Barthel ADL Index score of 19 or 20, or a Katz ADL
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score of 5 or 6. The Acute Physiology and Chronic Health
Evaluation II (APACHE II) score on admission to hospital
was calculated as a measure of physiological disturbance,
though without information on arterial blood gases and
haematocrit. Comorbid conditions were quantified with
the Charlson Comorbidity Index [32].
Sample collection, sample handling and laboratory
procedures
Venous blood was collected in 5-mL serum tubes from
hip fracture patients pre-operatively. After sampling, tubes
were left in the vertical position for 30 min at room
temperature for clotting before they were centrifuged. Ali-
quots of 200–500 μL were then stored at −80 °C in poly-
propylene tubes. CSF was collected at the onset of spinal
anaesthesia before administration of the anaesthetic agent.
CSF was collected in polypropylene tubes. The CSF was
centrifuged within 4 h, and the supernatant was stored in
aliquots of 100–1000 μL at −80 °C.
Samples were sent on dry ice to the University Medical
Center Rotterdam for analyses. Neopterin in serum and
CSF were measured by high-performance liquid chroma-
tography (HPLC) after acid oxidation, as previously
described [33]. The analyses were done in duplicate and
the technician was blinded to clinical data. The quantita-
tion was done by measuring peak heights and the recov-
eries were determined in every HPLC run by adding two
different amounts of neopterin to serum (99–109 %)
and/or CSF (97–101 %). In any subsequent HPLC run,
six samples of the former run were re-analysed to check
precision.
Statistical analyses
Categorical variables were analysed by the Chi-square
test. Continuous variables were analysed by Mann-Whitney
tests or t tests depending on the distribution of the data. In
our primary analysis, we compared the levels of neopterin
in CSF and serum between patients with and without
delirium by a Mann-Whitney U test. In a secondary
analysis, we divided the patients into four subgroups
based on delirium status and pre-fracture cognitive status
(stratified by IQCODE, cut point 3.44):
1. Neither delirium nor chronic cognitive impairment
2. Chronic cognitive impairment, but no delirium
3. Delirium, but no chronic cognitive impairment
4. Delirium superimposed on chronic cognitive
impairment
We also stratified the patients according to delirium
status at the time of sampling:
1. Prevalent delirium—those who had delirium when
CSF was taken
2. Incident delirium—those who were free from
delirium when CSF was taken but developed
delirium post-operatively
3. Subsyndromal delirium—those who at any point
(pre-operatively or post-operatively) experienced
some delirious symptoms (defined as at least two
positive CAM features) but never fulfilled the
criteria for full delirium [34]
4. Never delirium—those who never experienced
delirium or subsyndromal delirium
The Kruskal-Wallis test was used to assess potential
subgroup differences.
To assess the relationship between neopterin and delir-
ium when adjusting for other covariates, we performed lo-
gistic regression analyses, one with serum neopterin and
one with CSF neopterin as covariates, and both using ‘delir-
ium at any time’ as the outcome variable. The inclusion of
other covariates was based on a p value <0.1 in univariate
analyses. All analyses were on pooled data from both cen-
tres. To assess the possibility that differences in diagnostic
judgments between Oslo and Edinburgh could influence
delirium rates, ‘centre’ was forced in as a covariate in both
regression analyses.
Because a history of cancer and/or an ongoing infec-
tion and/or use of non-steroid anti-inflammatory drugs
(NSAIDs)/acetylsalicyclic acid (ASA) might influence
neopterin levels, we also ran analyses with patients with
any of these excluded. We also assessed the association
between neopterin and length of stay and the combined
endpoint ‘death/new nursing home admissions’ after
12 months.
All statistical analyses were performed using IBM SPSS
Statistics version 20.
Ethical considerations
The study was undertaken in accordance with the Dec-
laration of Helsinki. It was approved by the Regional
Committee for Ethics in Medical Research in Norway
and the Scotland A Regional Ethics Committee. At both
sites, informed consent was obtained from the patients
or from proxy decision-makers if patients did not have
capacity to consent.
Results
Paired CSF and serum samples were available from 139
hip fracture patients (Oslo n = 85; Edinburgh n = 54, Fig. 1).
Compared to patients recruited in Edinburgh, fewer pa-
tients in Oslo were independent in ADL and more had
pre-fracture cognitive impairment. More patients in Oslo
were diagnosed with delirium (Table 1). Neopterin was
detectable in all samples. No patients had a diagnosis
of HIV.
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Neopterin and delirium
Sixty-four (46 %) of the hip fracture patients developed
delirium at any time. Compared to patients without de-
lirium, delirious patients had higher levels of neopterin
in CSF (median 29.6 vs 24.7 nmol/mL, p = 0.003) and in
serum (median 37.0 vs 27.1 nmol/mL, p = 0.003), Table 1).
Stratified analysis showed that patients with both delirium
and chronic cognitive impairment had highest levels of
neopterin and those with neither had lowest. A similar
pattern was found in both CSF (p = 0.05, Fig. 2a) and in
serum (p = 0.009, Fig. 2b).
In both CSF and serum neopterin was highest in patients
with incident delirium (n = 28), followed by those with
prevalent delirium (n = 35). The group with subsyndromal
delirium (n = 21) had neopterin levels between the levels of
patients with no signs of delirium (n = 50) to those with full
syndromal delirium (Fig. 3).
In patients with delirium, there was a significant cor-
relation with delirium severity and neopterin levels in
the group without chronic cognitive impairment (CSF:
rho = 0.42, p = 0.044; serum: rho = 0.44, p = 0.037). The
same was not seen in patients with chronic cognitive im-
pairment (CSF: rho −0.05, p = 0.74; serum: rho = −0.17,
p = 0.30).
There was a near-linear relationship between delirium
rates and neopterin levels in serum. For CSF neopterin
levels there was a ‘cutoff ’ at the 75th percentile with a
steep rise in delirium rates above this ‘threshold’. In the
Fig. 1 Flow chart
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logistic regression analysis, serum neopterin was therefore
used as a continuous variable, whereas CSF neopterin was
dichotomized at the 75th percentile. Neopterin remained
a significant predictor of delirium in CSF (p = 0.02) and
showed a trend in serum (p = 0.08) when adjusting for
other risk factors in the logistic regression. The analysis
identified two other risk factors for delirium: waiting time
for surgery and higher IQCODE (see Table 2 for model
with CSF neopterin).
Neopterin and other outcomes
There was a significant correlation between neopterin
levels and length of stay in the whole study sample, both
in serum (rho = 0.20, p = 0.025) and in CSF (rho = 0.22,
p = 0.012). Twelve months after surgery, 32 patients had
died and 13 had been newly admitted into a nursing
home. When death and new nursing home admissions
were combined as ‘poor outcome’, both CSF and serum
neopterin levels during hospital stay were significantly
higher in patients with this poor outcome compared to
those without (CSF: median (IQR) 29.2 (22.8–39.6)
nmol/L vs 24.9 (19.4–33.2) nmol/L, p = 0.02; serum: me-
dian (IQR) 37.9 (26.8–54.4) nmol/L vs 29.2 (23.1–41.7)
nmol/L, p = 0.03).
Subgroup analyses
There were no significant differences in neopterin levels
in CSF (p = 0.30) or serum (p = 0.21) between patients
who were taking (n = 46) or were not taking NSAIDs/
ASA (n = 93). There were, however, trends that patients
with a history of cancer and/or an ongoing infection at
the time of admission (n = 22) had higher levels of neop-
terin in CSF (median (IQR) 30.3 (21.3–48.7) nmol/L vs
25.3 (19.8–33.8) nmol/L, p = 0.08) and serum (median
(IQR) 49.4 (24.7–69.3) nmol/L vs 29.4 (23.4–41.7) nmol/L,
p = 0.01). Accordingly, we carried out subgroup analyses
excluding these patients; the association between neop-
terin and delirium remained strong, both in CSF (median
(IQR) 29.3 (22.6–39.6) nmol/L vs 23.2 (18.6–28.5) nmol/L,
p = 0.001) and in serum (median (IQR) 37.0 (26.8–48.9)
nmol/L vs 26.4 (22.0–33.1) nmol/L, p < 0.001). When re-
gression analyses were performed only with patients with-
out cancer and/or infection, neopterin was significantly
associated with delirium both in the models with serum
(p = 0.01) and CSF (p = 0.01).
Relationship between neopterin in serum and CSF
There was a significant correlation between neopterin
levels in CSF and serum (rho = 0.65, p < 0.001). The median
CSF/serum ratio was 0.81, and there was no difference in
Table 1 Baseline characteristics of hip fracture patients. Patients are stratified by centre and delirium status
Centre Delirium status during hospital stayh
Oslo (n = 85) Edinburgh (n = 54) p value Delirium (n = 64) No delirium (n = 73) p value
Age, median (range) 84 (60–96) 83 (61–95) 0.18 85 (66–96) 82 (60–96) 0.02
Male (%) 19 (22) 17 (32) 0.23 19 (30) 17 (23) 0.40
IQCODE, median (IQR)a 3.66 (3.06–4.18) 3.00 (3.00–3.27) <0.001 3.81 (3.08–4.80) 3.03 (3.00–3.31) <0.001
Delirium during hospital stay (%) 43 (51)h 21 (39) 0.16
Independent in ADL (%)b 36 (42) 49 (91) <0.001 28 (44) 56 (77) <0.001
Living in an institution (%)c 30 (35) 0 <0.001 21 (33) 7 (10) 0.001
Presence of infection and/or cancer
pre-operatively (%)
11 (13) 11 (20) 0.24 12 (19) 10 (13.7) 0.42
APACHE II score, median (IQR)d 9 (7.3–10) 8 (6.8–10) 0.03 9 (8–10) 8 (7–10) 0.10
Charlson Comorbidity Index score, median (IQR) 1 (0–2) 1 (0–2) 0.66 1 (0–2) 1 (0–2) 0.06
Use of NSAIDs and/or ASA 23 (27) 23 (43) 0.06 22 (34) 24 (33) 0.85
Time from admission to surgery in hours,
median (IQR)e
28.6 (19.8–42.5) 35 (23–45.5) 0.10 36.1 (23.0–46.4) 27.4 (19.8–39.5) 0.02
Length of stay, days median (IQR) 10 (7–14) 20 (13–51) <0.001 13 (8–21.5) 11 (8–17) 0.52
Serum neopterin, median (IQR) nmol/mLf 28.6 (23.4–41.9) 36.1 (24.2–49.2) 0.13 37.0 (26.2–51.1) 27.1 (22.6–40.7) 0.003
CSF neopterin, median (IQR) nmol/mLg 25.1 (20.1–37.6) 25.9 (20.8–33.0) 0.76 29.6 (22.3–40.4) 24.7 (19.4–30.6) 0.003
IQCODE informant questionnaire on cognitive decline in the elderly, IQR interquartile range, ADL activities of daily living, APACHE II Acute Physiology and Chronic
Health Evaluation II, NSAIDs non-steroid anti-inflammatory drugs, ASA acetylsalicyclic acid
aIQCODE was missing in 1 patient in Oslo and 4 in Edinburgh
bBarthel ADL ≥19 (Oslo) or Katz ≥5 (Edinburgh)
cNursing home residents were excluded in Edinburgh
dArterial blood gas and haematocrit omitted from formula. Missing in one patient in Oslo
eWaiting time for surgery was missing in three patients from Edinburgh. One patient in Oslo did not undergo surgery
fIn six patients from Edinburgh, it was not possible to measure neopterin in serum due to an insufficient sample volume
gIn two patients from Oslo, it was not possible to measure neopterin in CSF due to an insufficient sample volume
hDelirium status was uncertain in 2 patients in Oslo
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patients with (median ratio 0.81) and without delirium
(median ratio 0.81, p = 0.62).
Discussion
This study found novel evidence of elevated CSF levels
of neopterin in delirium. This was present even when
participants with active infection and malignant disease
were excluded. These findings also confirm, though in a
different population, those of Osse et al. of elevated
serum neopterin in delirium [21]. These results suggest
that there may be greater activation of the cellular im-
mune response in delirium. They may also imply a role
for oxidative stress in delirium.
The source of CSF neopterin may be from the periph-
ery via the blood-brain barrier, but neopterin is also pro-
duced in significant quantities in the CNS, primarily by
microglia [17]. The neopterin molecule itself is small,
polar and stable in vivo with little cellular reuptake or
metabolic degradation, being renally excreted. CSF levels
of neopterin are generally half of those found in serum,
and CNS production is thought to be likely if the CSF/
serum ratio is greater than 1 [18, 35]. The ratio docu-
mented in this population was approximately 0.8 in all
groups, suggesting that, as the ratio is greater than 0.5,
there might be some in situ CNS production. Notably,
Kuehne et al. have previously demonstrated that CSF
neopterin is brain-derived in psychiatric patients and
normal controls [35].
Fig. 2 Neopterin levels in CSF (a) and serum (b) in hip fracture
patients stratified regarding acute (delirium) and chronic cognitive
impairment (neither: n = 56, chronic cognitive impairment only = 10,
delirium only = 24, both = 40) p = 0.05 for CSF and p = 0.01 for serum
(Kruskal-Wallis tests). The horizontal lines represent the median. Three
patients (one with ‘neither’ and two with ‘delirium only’) had CSF
neopterin above the upper margin of this figure. The Informant
Questionnaire on Cognitive Decline in the Elderly (IQCODE) cutoff of
3.44 was used as an indicator of chronic cognitive impairment
(missing in five patients)
Fig. 3 Neopterin levels in CSF (a) and serum (b) by delirium status.
p = 0.03 for CSF and p = 0.001 for serum (Kruskal-Wallis tests). No
delirium (n = 50): patients that never had delirium or SSD
(subsyndromal delirium). SSD (n = 21): patients that had some
features of delirium but never fulfilled the criteria for full delirium.
Incident delirium (n = 28): patients that were free from delirium
when sample was taken but developed delirium later. Prevalent
delirium (n = 35): those who had delirium when the samples were
taken. The horizontal lines represent the median. Pre-operative
delirium status missing in three patients. Three patients (one with
‘no delirium’ and two with ‘prevalent delirium’) had CSF neopterin
above the upper margin of this figure
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Elevation of neopterin in CSF in delirium points to-
wards the potential involvement of several pathogenetic
mechanisms, each of which needs to be explored in
more depth by future studies. Increased oxidative stress
is one plausible pathway [13]. Disruption in the energy
supply required to meet the brain’s high metabolic de-
mands likely results in acute disruption of neurotrans-
mission, and the brain’s sensitive attentional pathways
could plausibly be affected by this [5]. Activation of a
cell-mediated immune response would involve activation
of microglia, the brain’s resident macrophages. It is
known from animal models that microglia in aged brains
and those with neurodegenerative disease are ‘primed’
by these processes such that they respond more vigorously
to peripheral immune stimuli [36]. This is associated with
a transient decline in working memory (modelling the
transient decline in cognition in delirium) and also accel-
eration of the chronic neurodegenerative disease process,
and a parallel pathway is plausible here.
We found that patients with no underlying cognitive
impairment and no delirium had the lowest levels of
neopterin, and those with delirium superimposed on
chronic cognitive impairment had the highest levels. The
elevated levels in patients with chronic cognitive impair-
ment is consistent with what might be expected in the
presence of microglial priming, where pre-existing neu-
rodegeneration renders microglia more likely to produce
higher levels of pro-inflammatory mediators in response
to acute inflammatory stimuli. In patients with delirium
but no known pre-fracture dementia, this might not only
reflect pre-existing milder neurodegeneration and
microglial priming but may also be due to alternative
processes. It may be that both delirium and dementia
processes activate these systems with an additive effect
observed in those with both diagnoses.
CSF neopterin has been shown to be elevated in
CNS infections, including the acute phase of aseptic
meningo-encephalitis, with normalization following clin-
ical recovery [37]. It is also elevated in HIV, particularly
with concomitant neuropsychiatric sequelae [18] including
AIDS dementia [38]. It is present but not elevated in CSF
in Alzheimer’s dementia [20], and reduced in Parkinson’s
disease, reflecting a lack of biosynthesis and degeneration
of nigrostriatal pathways [39].
We found higher CSF neopterin levels in those who
had a poor outcome (death or new admission to care
home) at 1 year. High neopterin levels, indicating greater
immune system activation and oxidative stress, have
been shown to be associated with poor outcomes in a
range of conditions. High neopterin levels in cancer are
associated with poorer survival, and the development of
tumour-associated problems [16], they confer worse
prognostic risk in HIV infection [15] and predict poor
outcome in herpetic encephalitis [40].
This study has some limitations that should be acknowl-
edged. Due to the cross-sectional design, we are unable to
infer causation, although longitudinal CSF studies in delir-
ium are practically and ethically difficult. Due to the
nature of the different parent studies at the two sites, the
Oslo cohort was frailer than the Edinburgh cohort. It is
also difficult to rule out that there might have been some
differences in diagnostic judgment between the two
centres. The assessment tools for delirium were, how-
ever, similar and thorough and both centres used CAM
as the final diagnostic tool, and we included study site
in the logistic regression analyses to minimize bias.
Conclusions
This study is the first to examine neopterin levels in CSF
in delirium. We found higher levels in delirium. We also
Table 2 Logistic regression models of factors associated with delirium at any time
Unadjusted models Adjusted model
OR 95 % CI p value OR 95 % CI p value
Age (years) 1.07 1.02 to 1.11 0.004
IQCODE 4.56 2.43 to 8.52 <0.001 5.81 2.77 to 12.21 0.001
APACHE II score 1.11 0.96 to 1.27 0.15
Independent in ADL 0.24 0.12 to 0.49 <0.001
Time from admission to surgery, hours 1.02 1.00 to 1.05 0.046 1.04 1.01 to 1.07 0.017
Living in an institution 4.61 1.80 to 11.76 0.001
CSF Neopterin, nmol/La 3.67 1.58 to 8.47 0.002 3.31 1.24 to 8.86 0.017
Centre (reference: Oslo) 0.59 0.30 to 1.19 0.14 0.58 0.22 to 1.52 0.27
n = 127 in the regression analyses, some patients had to be excluded due to missing data. Variables associated with delirium in univariate analysis (p < 0.1) were
considered for inclusion in the multivariate model, and variables were removed one by one by backwards stepping until the final model was reached. Centre
(Oslo or Edinburgh) was, however, forced into the final model
IQCODE informant questionnaire on cognitive decline in the elderly, APACHE II Acute Physiology and Chronic Health Evaluation II, ADL activities of daily living,
CSF cerebrospinal fluid
aCSF neopterin dichotomized at the 75th percentile
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replicated a prior study showing higher serum neopterin
in delirium. Our findings suggest potential roles for
activation of cell-mediated immune responses and/or
oxidative stress in the delirium process. High levels may
also be useful in predicting poor outcomes. Future work
should examine these results in the context of other CSF
biomarkers, including markers of oxidative stress, IFN-γ
and other components of the cellular immune response. It
would also be useful to examine CSF and serum neopterin
levels in delirium in other patient populations, contribut-
ing to the overall body of knowledge examining the role of
inflammatory processes in delirium.
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